Motus GI Holdings EPS - Earnings per Share 2016-2023 | MOTS
Motus GI Holdings eps - earnings per share from 2016 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Motus GI Holdings Annual EPS | |
|---|---|
| 2023 | $-15.89 |
| 2022 | $-86.15 |
| 2021 | $-161.02 |
| 2020 | $-179.91 |
| 2019 | $-275.86 |
| 2018 | $-440.78 |
| 2017 | $-383.81 |
| 2016 | $-2,098.95 |
| 2015 | $-1,910.05 |
| Motus GI Holdings Quarterly EPS | |
|---|---|
| 2023-12-31 | $8.18 |
| 2023-09-30 | $-4.28 |
| 2023-06-30 | $-6.00 |
| 2023-03-31 | $-13.79 |
| 2022-12-31 | $-3.39 |
| 2022-09-30 | $-26.99 |
| 2022-06-30 | $-27.89 |
| 2022-03-31 | $-27.89 |
| 2021-12-31 | $-26.24 |
| 2021-09-30 | $-29.99 |
| 2021-06-30 | $-29.84 |
| 2021-03-31 | $-74.96 |
| 2020-12-31 | $-26.99 |
| 2020-09-30 | $-38.98 |
| 2020-06-30 | $-44.98 |
| 2020-03-31 | $-68.97 |
| 2019-12-31 | $-56.97 |
| 2019-09-30 | $-53.97 |
| 2019-06-30 | $-77.96 |
| 2019-03-31 | $-86.96 |
| 2018-12-31 | $-89.96 |
| 2018-09-30 | $-98.95 |
| 2018-06-30 | $-80.96 |
| 2018-03-31 | $-170.92 |
| 2017-12-31 | $-110.95 |
| 2017-09-30 | $-89.96 |
| 2017-06-30 | $-98.95 |
| 2017-03-31 | $-83.96 |
| 2016-12-31 | $0.00 |
| 2016-09-30 | $-497.75 |
| 2015-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also operates through subsidiaries in the U.S. and Israel. Motus GI Holdings, Inc. is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.069B | 20.90 |
| Inspire Medical Systems (INSP) | United States | $4.986B | 0.00 |
| Axonics (AXNX) | United States | $3.440B | 0.00 |
| 10x Genomics (TXG) | United States | $3.097B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.080B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.900B | 0.00 |
| Azenta (AZTA) | United States | $2.877B | 156.36 |
| Enovis (ENOV) | United States | $2.801B | 20.76 |
| Hims & Hers Health (HIMS) | United States | $2.633B | 0.00 |
| Privia Health (PRVA) | United States | $2.132B | 119.80 |
| Schrodinger (SDGR) | United States | $1.644B | 0.00 |
| Omnicell (OMCL) | United States | $1.383B | 47.81 |
| Phreesia (PHR) | United States | $1.205B | 0.00 |
| Standard BioTools (LAB) | United States | $0.696B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.627B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.406B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.378B | 0.00 |
| Pulmonx (LUNG) | United States | $0.326B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.306B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.215B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.212B | 0.00 |
| Outset Medical (OM) | United States | $0.159B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| TruBridge (TBRG) | United States | $0.129B | 7.07 |
| MSP Recovery (LIFW) | United States | $0.121B | 0.00 |
| Augmedix (AUGX) | United States | $0.109B | 0.00 |
| 111 (YI) | China | $0.095B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.078B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |